Yang Feng

74 Linjiang Road
Linjiang, 400010, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction: P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats.

Correction: P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats.

Journal: Scientific reports

Published: June 04, 2026

Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?

Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?

Journal: Oral oncology

Published: October 21, 2025

Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.

Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.

Journal: BMC cancer

Published: February 06, 2025

Prediction of non-sentinel lymph node metastases in T1-2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy.

Prediction of non-sentinel lymph node metastases in T1-2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy.

Journal: World journal of surgical oncology

Published: April 11, 2024

Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.

Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.

Journal: Frontiers in endocrinology

Published: February 28, 2023

The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.

The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: February 06, 2023

Stigma type and transcriptome analyses of mulberry revealed the key factors associated with Ciboria shiraiana resistance.

Stigma type and transcriptome analyses of mulberry revealed the key factors associated with Ciboria shiraiana resistance.

Journal: Plant physiology and biochemistry : PPB

Published: December 16, 2022

A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancer.

A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancer.

Journal: Frontiers in endocrinology

Published: December 11, 2022

Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients.

Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients.

Journal: Frontiers in oncology

Published: July 11, 2022

Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.

Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.

Journal: Frontiers in endocrinology

Published: February 03, 2022

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer.

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer.

Journal: Frontiers in immunology

Published: January 15, 2022

High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.

High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.

Journal: NPJ breast cancer

Published: December 08, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026